Blauvelt, A.; Strober, B.; Langley, R.; Burge, D.; Pisenti, L.; Yassine, M.; Kavanagh, S.; Arendt, C.; Rolleri, R.; Reich, K. Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies. J of Skin 2018, 2, S16.